GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0070986
|
BP
|
left/right axis specification
|
The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes).
|
NOTCH1,
AHI1,
MNS1,
SETDB2,
PITX2,
CITED2,
HSPB11
|
GO:0070987
|
BP
|
error-free translesion synthesis
|
The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions but does not causes an increase in the endogenous mutation level. For S. cerevisiae, RAD30 encodes DNA polymerase eta, which incorporates two adenines. When incorporated across a thymine-thymine dimer, it does not increase the endogenous mutation level.
|
UBC,
PCNA,
RPA3,
RFC4,
RFC2,
RFC5,
RFC3,
VCP,
RPS27A,
UBA52,
UFD1L,
POLH
|
GO:0070988
|
BP
|
demethylation
|
The process of removing one or more methyl groups from a molecule.
|
CYP1A1,
CYP51A1
|
GO:0070989
|
BP
|
oxidative demethylation
|
The process of removing one or more methyl groups from a molecule, involving the oxidation (i.e. electron loss) of one or more atoms in the substrate.
|
CYP3A4,
CYP2D6,
CYP2C9,
CYP3A5,
ALKBH1,
FTO
|
GO:0070994
|
BP
|
detection of oxidative stress
|
The series of events in which a stimulus indicating oxidative stress is received and converted into a molecular signal.
|
ADIPOQ
|
GO:0070995
|
BP
|
NADPH oxidation
|
A metabolic process that results in the oxidation of reduced nicotinamide adenine dinucleotide, NADPH, to the oxidized form, NADP.
|
FMO2
|
GO:0070997
|
BP
|
neuron death
|
The process of cell death in a neuron.
|
DPYSL4,
NLRP5,
MAGI1,
BAG5
|
GO:0071000
|
BP
|
response to magnetism
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus.
|
TJP1
|
GO:0071025
|
BP
|
RNA surveillance
|
The set of processes involved in identifying and degrading defective or aberrant RNAs.
|
PELO
|
GO:0071028
|
BP
|
nuclear mRNA surveillance
|
The set of processes involved in identifying and degrading defective or aberrant mRNAs within the nucleus.
|
DXO,
EXOSC9,
EXOSC7,
EXOSC6,
XRN1,
EXOSC8,
EXOSC4
|
GO:0071034
|
BP
|
CUT catabolic process
|
The chemical reactions and pathways resulting in the breakdown of cryptic unstable transcripts (CUTs).
|
EXOSC2,
EXOSC3,
DIS3
|
GO:0071035
|
BP
|
nuclear polyadenylation-dependent rRNA catabolic process
|
The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a ribosomal RNA (rRNA) molecule, including RNA fragments released as part of processing the primary transcript into multiple mature rRNA species, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target rRNA.
|
EXOSC9,
EXOSC2,
EXOSC7,
EXOSC8,
EXOSC3
|
GO:0071038
|
BP
|
nuclear polyadenylation-dependent tRNA catabolic process
|
The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of an aberrant or incorrectly modified transfer RNA (tRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target tRNA.
|
EXOSC9,
EXOSC2,
EXOSC7,
EXOSC8,
EXOSC3
|
GO:0071042
|
BP
|
nuclear polyadenylation-dependent mRNA catabolic process
|
The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target mRNA.
|
EXOSC9,
EXOSC7,
PNPT1,
EXOSC8
|
GO:0071044
|
BP
|
histone mRNA catabolic process
|
The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA).
|
PAPD4,
DCP2,
XRN1,
PAPD5,
EXOSC4,
MTPAP
|
GO:0071048
|
BP
|
nuclear retention of unspliced pre-mRNA at the site of transcription
|
The process involved in retention of incorrectly or incompletely spliced pre-mRNA within the nucleus at the site of transcription.
|
PRPF18
|
GO:0071049
|
BP
|
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription
|
The process involved in retention of mRNAs that have incorrectly formed 3'-ends within the nucleus at the site of transcription.
|
EXOSC2,
EXOSC3
|
GO:0071051
|
BP
|
polyadenylation-dependent snoRNA 3'-end processing
|
Any process involved in forming the mature 3' end of a snoRNA molecule linked to prior polyadenylation of the 3'-end of the precursor snoRNA.
|
EXOSC2,
EXOSC6,
EXOSC4,
EXOSC3
|
GO:0071071
|
BP
|
regulation of phospholipid biosynthetic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.
|
IDH1
|
GO:0071072
|
BP
|
negative regulation of phospholipid biosynthetic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.
|
SLC27A1
|
GO:0071073
|
BP
|
positive regulation of phospholipid biosynthetic process
|
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.
|
FABP3
|
GO:0071103
|
BP
|
DNA conformation change
|
A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule.
|
HHEX
|
GO:0071104
|
BP
|
response to interleukin-9
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-9 stimulus.
|
JAK3,
CITED1
|
GO:0071105
|
BP
|
response to interleukin-11
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-11 stimulus.
|
CITED1
|
GO:0071107
|
BP
|
response to parathyroid hormone
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus.
|
PTH,
ITGA2,
CITED1
|
GO:0071108
|
BP
|
protein K48-linked deubiquitination
|
A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein.
|
USP27X,
TNFAIP3,
ATXN3,
OTUD7B,
USP34,
BAP1,
OTUB2,
OTUB1,
VCPIP1,
USP25,
USP20
|
GO:0071109
|
BP
|
superior temporal gyrus development
|
The process whose specific outcome is the progression of the superior temporal gyrus over time, from its formation to the mature structure. The superior temporal gyrus is a portion of the cerebral cortex that extends from the lateral sulcus to the superior temporal sulcus.
|
GSK3B
|
GO:0071139
|
BP
|
resolution of recombination intermediates
|
The cleavage and rejoining of intermediates, such as Holliday junctions, formed during DNA recombination to produce two intact molecules in which genetic material has been exchanged.
|
SMC5,
SMC6
|
GO:0071156
|
BP
|
regulation of cell cycle arrest
|
Any process that modulates the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
|
BIN1,
AKT2,
CDK5,
FOXM1
|
GO:0071157
|
BP
|
negative regulation of cell cycle arrest
|
Any process that decreases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
|
MDM4,
CDK4,
MIF,
MDM2,
ZNF268,
GPER1
|
GO:0071158
|
BP
|
positive regulation of cell cycle arrest
|
Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
|
TGFB1,
TP53,
PRKACA,
BRCA1,
HMGA2,
FOXO4,
INSM1,
ID2,
PKD2,
PPP2R5B,
CRLF3,
GATA6,
UHRF2,
MYBBP1A,
RGCC
|
GO:0071166
|
BP
|
ribonucleoprotein complex localization
|
Any process in which a ribonucleoprotein complex is transported to, or maintained in, a specific location within a cell.
|
PRPF31
|
GO:0071168
|
BP
|
protein localization to chromatin
|
Any process in which a protein is transported to, or maintained at, a part of a chromosome that is organized into chromatin.
|
RAD21,
ESR1,
PLK1,
EZH2,
ESCO2,
WAPL
|
GO:0071169
|
BP
|
establishment of protein localization to chromatin
|
The directed movement of a protein to a part of a chromosome that is organized into chromatin.
|
H2AFY,
SGF29,
H2AFY2,
LRWD1,
RUVBL2
|
GO:0071171
|
BP
|
site-specific DNA replication termination at RTS1 barrier
|
A DNA replication termination process that takes place at the RTS1 termination site in the mating type locus, in a specific direction required for subsequent imprinting and mating-type switching.
|
RTFDC1
|
GO:0071173
|
BP
|
spindle assembly checkpoint
|
A cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle.
|
BUB1,
BUB3,
CASC5
|
GO:0071205
|
BP
|
protein localization to juxtaparanode region of axon
|
Any process in which a protein is transported to, or maintained at, the juxtaparanode region of an axon.
|
EPB41L3
|
GO:0071218
|
BP
|
cellular response to misfolded protein
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus.
|
ATXN3,
UBE2W,
HDAC6,
STUB1
|
GO:0071219
|
BP
|
cellular response to molecule of bacterial origin
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
SIRT2
|
GO:0071221
|
BP
|
cellular response to bacterial lipopeptide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bacterial lipopeptide stimulus.
|
TLR2,
TIRAP
|
GO:0071222
|
BP
|
cellular response to lipopolysaccharide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
TLR4,
TLR5,
ABCA1,
ASS1,
SERPINE1,
IL6,
ICAM1,
CD14,
GSTP1,
CXCL8,
TFPI,
CCL2,
CD36,
CEBPB,
XBP1,
NFKB1,
TNFRSF1B,
NR1D1,
TNFAIP3,
IL10,
MRC1,
TNFSF4,
HMGB2,
ZFP36,
IL12A,
TSPO,
WNT5A,
MAPK8,
STAR,
B2M,
CCL20,
HAMP,
HSF1,
PPARD,
RELA,
MEF2C,
PDE4D,
NR1H3,
ADAM9,
ANKRD1,
MAPK14,
CMPK2,
PABPN1,
LILRB1,
NR1H4,
LITAF,
VIMP,
SPON2,
CDK19,
CXCL16,
PLSCR4,
NFKBIL1,
PPARGC1A,
SHPK,
PYCARD,
HDAC5
|
GO:0071223
|
BP
|
cellular response to lipoteichoic acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipoteichoic acid stimulus; lipoteichoic acid is a major component of the cell wall of gram-positive bacteria and typically consists of a chain of glycerol-phosphate repeating units linked to a glycolipid anchor.
|
TLR4,
RIPK2,
TLR2,
CD14,
CD36,
TIRAP,
CCL20
|
GO:0071224
|
BP
|
cellular response to peptidoglycan
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule.
|
RIPK2
|
GO:0071225
|
BP
|
cellular response to muramyl dipeptide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan.
|
RIPK2,
ARHGEF2,
PTPN22
|
GO:0071226
|
BP
|
cellular response to molecule of fungal origin
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of fungal origin such as chito-octamer oligosaccharide.
|
SYK,
CLEC7A
|
GO:0071228
|
BP
|
cellular response to tumor cell
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a tumor cell.
|
TXNIP
|
GO:0071230
|
BP
|
cellular response to amino acid stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
|
IPO5,
SOCS1,
EGFR,
ASS1,
TNF,
COL1A1,
COL3A1,
COL5A2,
COL1A2,
MMP2,
COL6A1,
CEBPB,
XBP1,
DNMT1,
ZEB1,
SESN2,
SESN3,
COL16A1,
HNRNPD,
NTRK2,
CPEB4,
LAMTOR1,
NSMF,
SLC38A9,
CPEB3,
PDGFD,
RRAGC,
RRAGD,
PDGFC,
SH3BP4,
LAMTOR3,
LAMTOR2,
SESN1
|
GO:0071231
|
BP
|
cellular response to folic acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus.
|
FOLR1
|
GO:0071233
|
BP
|
cellular response to leucine
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leucine stimulus.
|
SESN2,
UBR1
|
GO:0071236
|
BP
|
cellular response to antibiotic
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.
|
HSPA5,
CDKN1B,
PLA2G4A,
STAR,
MDM2
|
GO:0071242
|
BP
|
cellular response to ammonium ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium ion stimulus.
|
ASS1
|
GO:0071243
|
BP
|
cellular response to arsenic-containing substance
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides.
|
DDX3X,
HMOX1,
PPIF,
GSTO1,
CPEB2,
GSTO2,
MKNK2
|
GO:0071247
|
BP
|
cellular response to chromate
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chromate stimulus.
|
BAD
|
GO:0071248
|
BP
|
cellular response to metal ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
|
HSD17B1
|
GO:0071250
|
BP
|
cellular response to nitrite
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrate stimulus.
|
PPARGC1A
|
GO:0071257
|
BP
|
cellular response to electrical stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
|
ADSS,
NSMF,
ADSSL1
|
GO:0071258
|
BP
|
cellular response to gravity
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gravitational stimulus.
|
PTAFR
|
GO:0071259
|
BP
|
cellular response to magnetism
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus.
|
ASCL1
|
GO:0071260
|
BP
|
cellular response to mechanical stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
TLR4,
CHEK1,
TLR3,
TLR5,
BCL10,
EGFR,
AGT,
TGFB1,
IL1B,
COL1A1,
IRF1,
ITGA2,
GJA1,
NFKB1,
MAG,
BMP6,
GADD45A,
FAS,
MAPK3,
TNFRSF8,
CASP1,
AKT1,
PTGS2,
PTGER4,
LTBR,
MAPK8,
SOX9,
GCLC,
ATP1A2,
HDAC4,
MTPN,
RAC1,
CRADD,
BNIP3,
FADD,
CASP8,
ANKRD1,
HABP4,
BAD
|
GO:0071264
|
BP
|
positive regulation of translational initiation in response to starvation
|
Any process that activates or increases the frequency, rate or extent of translation initiation, as a result of deprivation of nourishment.
|
EIF2AK4,
IMPACT
|
GO:0071266
|
BP
|
de novo' L-methionine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of L-methionine, the L-enantiomer of (2S)-2-amino-4-(methylsulfanyl)butanoic acid, from simpler components.
|
CTH
|
GO:0071268
|
BP
|
homocysteine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of homocysteine, 2-amino-4-sulfanylbutanoic acid.
|
AHCY
|
GO:0071276
|
BP
|
cellular response to cadmium ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
MT1E,
MT1F,
CYBB,
HMOX1,
MT1G,
MT3,
AKR1C3,
STAR,
MT1H,
MT1X
|
GO:0071277
|
BP
|
cellular response to calcium ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
RASA4,
FOS,
EDN1,
JUN,
ALOX15,
JUNB,
JUND,
CAPN3,
SYT1,
PPIF,
FUS,
WNT5A,
AKR1C3,
IQGAP1,
FOSB,
GPLD1,
MEF2A,
MEF2C,
CAMK2D,
RYR3,
RASGRP2,
CPNE2,
SLC25A23,
ECT2,
CACYBP
|
GO:0071279
|
BP
|
cellular response to cobalt ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus.
|
SERPINF1,
BNIP3
|
GO:0071280
|
BP
|
cellular response to copper ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
|
PRNP,
MT1G,
SNCA,
AQP2
|
GO:0071281
|
BP
|
cellular response to iron ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
|
TF,
BMP6,
B2M,
HFE,
TFR2
|
GO:0071283
|
BP
|
cellular response to iron(III) ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(III) ion stimulus.
|
CCNB1
|
GO:0071284
|
BP
|
cellular response to lead ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lead ion stimulus.
|
ALAD
|
GO:0071285
|
BP
|
cellular response to lithium ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
|
FABP4,
FAS,
CALR,
CDKN1B,
ID2,
XRCC4,
NFATC4,
TPH2
|
GO:0071286
|
BP
|
cellular response to magnesium ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus.
|
FBP1,
KCNA1,
ANK3,
RYR3
|
GO:0071287
|
BP
|
cellular response to manganese ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a manganese ion stimulus.
|
PARK2,
TH,
HSPA5,
ATP13A2
|
GO:0071288
|
BP
|
cellular response to mercury ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
|
AQP2
|
GO:0071294
|
BP
|
cellular response to zinc ion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
KCNK3,
MT2A,
MT1E,
MT1F,
PARP1,
MT1G,
CREB1,
TSPO,
MT1H,
MT1X,
ZNF658,
MT1M,
ATP13A2
|
GO:0071298
|
BP
|
cellular response to L-ascorbic acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus.
|
LEP
|
GO:0071300
|
BP
|
cellular response to retinoic acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
|
OGT,
HOXA2,
TBX1,
KLF4,
BRINP1,
FZD7,
ALDH1A2,
ABCA1,
COL1A1,
LYN,
WNT2,
CCL2,
KRT13,
TNC,
EPHA3,
LTK,
PCK1,
SERPINF1,
PPARG,
LEP,
WNT5A,
ABL2,
YAP1,
SOX9,
WNT3,
MEF2C,
PTK7,
TEAD2,
TWF2,
ADNP2,
SETX,
KMT2E,
OSR1,
HDAC2,
WNT5B,
CYP26B1,
NDUFA13,
FZD4,
WNT6
|
GO:0071301
|
BP
|
cellular response to vitamin B1
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B1 stimulus.
|
MDM2
|
GO:0071305
|
BP
|
cellular response to vitamin D
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
|
PENK,
BGLAP,
ATP2B1,
TNC,
SFRP1
|
GO:0071306
|
BP
|
cellular response to vitamin E
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus.
|
COL1A1,
PPARG
|
GO:0071307
|
BP
|
cellular response to vitamin K
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus.
|
GAS6,
POSTN
|
GO:0071310
|
BP
|
cellular response to organic substance
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
IL1B,
CLEC3B,
PSAP,
BCL2,
EGR2,
CASP1,
CD68,
TIMP3,
IQGAP3
|
GO:0071312
|
BP
|
cellular response to alkaloid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
|
ICAM1,
STAR,
MDM2,
TRPV1
|
GO:0071313
|
BP
|
cellular response to caffeine
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them.
|
GSTM2,
RYR3,
RYR2,
SEPN1,
PPARGC1A
|
GO:0071314
|
BP
|
cellular response to cocaine
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.
|
CCNA2
|
GO:0071316
|
BP
|
cellular response to nicotine
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
TNF,
NTRK1,
TH,
NFKB1,
RELA,
KCNJ11,
BAD
|
GO:0071318
|
BP
|
cellular response to ATP
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.
|
CCL2,
HSP90B1,
PTGS2,
RYR3,
TRPV1,
P2RX4
|
GO:0071320
|
BP
|
cellular response to cAMP
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
AQP9,
KDM1A,
AQP8,
ASS1,
PENK,
APP,
RPLP0,
CFTR,
EZR,
SRD5A1,
WT1,
IGFBP5,
PTAFR,
PCK1,
PIK3CG,
STAR,
STC1,
RAP1A,
ZFP36L1,
AKAP6,
RAPGEF1,
ITPR2,
ADIPOQ,
SLC5A5,
INPP5K,
NOX4
|
GO:0071321
|
BP
|
cellular response to cGMP
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus.
|
PDE3A
|
GO:0071322
|
BP
|
cellular response to carbohydrate stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus.
|
PRKCB,
RPS6KA2
|
GO:0071332
|
BP
|
cellular response to fructose stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fructose stimulus.
|
XBP1,
SLC2A5,
PCK1,
PPARGC1A
|
GO:0071333
|
BP
|
cellular response to glucose stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
FOXO3,
ERN1,
ICAM1,
TH,
LGALS1,
NME1,
PRKACA,
XBP1,
NME2,
SERPINF1,
PIK3CA,
GATA4,
GCLC,
GCLM,
STAR,
POLG,
UCP2,
RAP1A,
RACK1,
MEF2C,
SOX4,
TJP1,
PPP3CA,
GAS6,
KCNJ11,
PCK2,
AACS,
CPB2,
PEO1,
GPER1,
SLC29A1,
NOX4,
PPARGC1A,
ZNF236,
IRS2
|
GO:0071338
|
BP
|
positive regulation of hair follicle cell proliferation
|
Any process that activates or increases the rate or extent of hair follicle cell proliferation.
|
CDC42
|
GO:0071340
|
BP
|
skeletal muscle acetylcholine-gated channel clustering
|
The accumulation of acetylcholine-gated cation channels in a narrow, central region of muscle fibers, in apposition to nerve terminals.
|
MUSK,
ETV5,
COLQ
|
GO:0071344
|
BP
|
diphosphate metabolic process
|
The chemical reactions and pathways involving diphosphate, the anion or salt of diphosphoric acid.
|
PPA2
|
GO:0071345
|
BP
|
cellular response to cytokine stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
HAX1,
CSF1R,
MME,
HCLS1,
CXCR4,
AKAP6,
DPYSL3,
PID1,
KHSRP
|
GO:0071346
|
BP
|
cellular response to interferon-gamma
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
|
TLR3,
DAPK3,
SYNCRIP,
ASS1,
GAPDH,
EDN1,
EPRS,
CCL3,
CCL4,
TDGF1,
CCL2,
CCL5,
CD58,
HLA-DPA1,
MRC1,
RPL13A,
WNT5A,
IL12RB1,
STAR,
DAPK1,
CCL20,
CCL8,
GBP6
|
GO:0071347
|
BP
|
cellular response to interleukin-1
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
FGB,
IL6,
EDN1,
ICAM1,
CXCL8,
CCL3,
TFPI,
CCL4,
CCL2,
CCL5,
CEBPB,
NFKB1,
YY1,
RORA,
PCK1,
CHI3L1,
RBMX,
SOX9,
ADAMTS12,
CCL20,
CCL8,
RELA,
HYAL2,
ANKRD1,
PTGIS,
HIF1A,
SFRP1,
HAS2,
TANK,
OTUB1,
ADAMTS7,
PYCARD,
KLF2
|
GO:0071352
|
BP
|
cellular response to interleukin-2
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-2 stimulus.
|
CDC5L
|
GO:0071353
|
BP
|
cellular response to interleukin-4
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
|
RPLP0,
HSP90AB1,
HSPA5,
ALAD,
XBP1,
MRC1,
CORO1A,
FASN,
MCM2,
TUBA1B,
NFIL3,
SHPK
|
GO:0071354
|
BP
|
cellular response to interleukin-6
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus.
|
TDGF1,
CCL2,
NFKB1,
PHB,
HAMP,
RELA,
SELPLG,
PTGIS,
PID1,
PPARGC1A,
ST3GAL6
|